Ablynx is a subsidiary of biopharmaceutical company Sanofi engaged in the discovery and development of nanobodies, based in Science Park Zwijnaarde, Ghent. In November 2001, Ablynx was established as a spin-off of the Vlaams Instituut voor Biotechnologie (VIB) and the Free University of Brussels (VUB). Seed financing of €2 million was provided by Gimv. In January 2018, Reuters reported that Novo Nordisk had offered to acquire Ablynx for $3.1 billion — having made an unreported offer in mid-December for the company. However, the Ablynx board rejected this offer the same day, saying that the price undervalued the business. More information...
According to PR-model, ablynx.com is ranked 850,716th in multilingual Wikipedia, in particular this website is ranked 495,942nd in English Wikipedia.
The website is placed before shayegan.ir and after tokeibegin.jp in the BestRef global ranking of the most important sources of Wikipedia.
